A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.
about
Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants.A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsAnti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.Intravaginal and intrarectal microbicides to prevent HIV infection.Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action.PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialThe cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India.Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions.HIV entry inhibitors and their potential in HIV therapyConsiderations and development of topical microbicides to inhibit the sexual transmission of HIV.Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenFormulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.Microbicides: a new approach to preventing HIV and other sexually transmitted infections.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus.Non-specific microbicide product development: then and nowPreclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.Clinical microbicide research: an overview.Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraceptionFactors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel.Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycansComparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assayAn evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.Vaginal microbicides and the prevention of HIV transmissionVaginal drug delivery systems for HIV prevention.In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmissionHIV sexual transmission and microbicides.Critical design features of phenyl carboxylate-containing polymer microbicides.In vitro activity of polyhydroxycarboxylates against herpesviruses and HIV.Immunity in the female lower genital tract and the impact of HIV infection.Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.Fusion/entry inhibitors as therapies for HIV.An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.
P2860
Q24794033-906FC2B3-17E6-40BA-B086-D3872E0DA27FQ30356032-0A70127B-91C8-42C1-97B4-0EFF2282FB2CQ30369008-DB3A7B2A-2720-4451-B6DC-541885663E86Q33223969-8E1587EA-1755-48E0-9D32-A6A3AF125A4CQ33388659-90A7A4FA-79F6-4FD5-9EA6-CEBA1FAB9860Q33833110-A1BC5C65-0BB2-43E0-BFA9-6E6DCFEB4251Q33935475-9D6FEA06-8B68-4B19-AE80-415F9F4C782DQ34138687-C4F21ABE-D6C9-46D7-B2B4-8A59BD15E62BQ34142834-F18CE2C9-2243-45A7-B3FD-4A4F0A45126BQ34538247-542703AE-E95F-4270-9DA0-8C720C54C2CBQ34558034-C7895D0D-4BFF-4494-8026-E5026640B5C7Q34595921-385B08D3-3DAE-4C4C-B216-8BC0791F1BEFQ34768558-0FA30BCA-1153-490C-9EE5-75C1CCA2B9A6Q34874237-130B803B-C100-47A6-9B9D-527E92DDBCC1Q34932706-B15468A0-C42E-48FF-99C3-FC31A87D8D9CQ35013981-AE79DA16-0291-4BF3-87B6-51B0C727B623Q35042482-DF2702F7-F178-475F-8B93-9608C4EC41DAQ35175233-2D39851B-496E-449A-A467-E713E2A09D03Q35345283-1BCBAA4A-4F37-4520-BFFC-7815C2801A05Q35759112-A883CC1C-E782-4F8C-9C21-AD50A746766DQ35983532-CA8E1E25-E961-4C23-9FAA-027A8B73C88CQ36016276-1EFB72E2-B550-4E87-A9DE-E88996C5B52AQ36111516-A606FF18-22C6-4BAA-8D05-F4F770C9F25DQ36331527-9461407A-E69B-48FD-9077-64ADFB4A83F9Q36386833-FA295C3A-4263-498B-89DE-EDEB7A107121Q36464718-3356BC5A-B29B-4801-B068-C6E238913F5CQ36803970-8ADD1013-E982-4745-A828-12748FAC3060Q36906506-BCE3D9CB-F030-4055-A192-74E732F5C8D5Q37063819-108EEFF5-BC01-4F58-8956-59F930078138Q37149107-22DC20BE-D21E-4D38-9278-15559E457305Q37568492-D6B8296C-C8FA-4922-B8C0-B81701BA2EA9Q37853935-31965E0C-4BC2-457C-B740-61048D0F391DQ39383159-62A8ACDA-48F6-4C5D-BDE2-E920F0002A33Q40730797-FEBE4286-F691-4624-B7B0-62DA0F95D9EFQ44212305-D5FFC484-3337-498C-8D8F-76C6B2AFBFB5Q50977890-CACF821C-5AC3-4EC8-B22F-475EFE651229Q53853233-BC4F26AF-D71E-4591-9AAE-AC1846F76AB6Q55516259-F183A6A1-DAEE-42EA-BCEE-EB08876F7C4A
P2860
A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A phase I study of a novel pot ...... althy sexually inactive women.
@ast
A phase I study of a novel pot ...... althy sexually inactive women.
@en
type
label
A phase I study of a novel pot ...... althy sexually inactive women.
@ast
A phase I study of a novel pot ...... althy sexually inactive women.
@en
prefLabel
A phase I study of a novel pot ...... althy sexually inactive women.
@ast
A phase I study of a novel pot ...... althy sexually inactive women.
@en
P2093
P2860
P356
P1476
A phase I study of a novel pot ...... althy sexually inactive women.
@en
P2093
E Van Dyck
I Rosenstein
K Depraetere
L Van Damme
M McKinlay
P2860
P304
P356
10.1136/STI.76.2.126
P577
2000-04-01T00:00:00Z